Dr. Eva Feldman commemorates Alfred Taubman
A. Alfred Taubman, one of the world's leading champions of bold approaches to medical research, passed away at age 91 on April 18, 2015. One of his enduring legacies will be the groundbreaking work of the clincian-scientists whose work has been accelaterated by the charge from the Taubman Institute to use unrestricted financial grants to follow their hunches and establish new paradigms in the development of cures and diseases for mankind's most difficult diseases.
“All of us who knew and worked with Mr. Taubman are deeply grieving his passing. But at the same time we are grateful for his extreme generosity, wise leadership and limitless ability to make change happen,” said Eva L. Feldman, M.D., Ph.D., director of the A. Alfred Taubman Medical Research Institute at the University of Michigan.
“The source of Mr. Taubman’s greatness lies in his bold, visionary thinking and his willingness to take bold risks that changed conventional thinking in every area he touched. The immeasurable benefits his work will bring to future generations will be the legacy of his passion, his inspiration and his unmatched ability to achieve grand results.”
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
Emerging Scholars publish new findings on basal cell cancer
Ophthalmologists Alon Kahana, MD, PhD and Rajesh Rao, MD are trying to pinpoint when the common cancer turns dangerous.
Dr. Max Wicha receives $6.5 million to target cancer stem cells
The award from the National Cancer Institute will fuel research into the cells that cause metastasis.
news & events
In the News
Taubman Emerging Scholar partners in ACL repair study
Asheesh Bedi, M.D., is an investigator in a study using human growth hormone to aid healing of the common knee injury.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D. and team find a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Arthritis drug may help diabetics with kidney disease
Research led by Taubman Scholar Frank Brosius has led to a fast-track study that shows promising results